| Quarterly Financials | Jun 2024 | Mar 2025 | Jun 2025 |
| Revenue | 358 | 497 | 563 |
| Expenses | 218 | 288 | 349 |
| EBITDA | 140 | 209 | 214 |
| Operating Profit % | 36 % | 40 % | 35 % |
| Depreciation | 19 | 30 | 27 |
| Interest | 4 | 1 | 2 |
| Profit Before Tax | 118 | 178 | 186 |
| Tax | 36 | 96 | 51 |
| Net Profit | 82 | 83 | 136 |
| EPS in ₹ | 1.47 | 1.48 | 2.43 |

Quant Small Cap Fund Direct Plan-Growth
Kotak Small Cap Fund Direct-Growth
HSBC Midcap Fund Direct-Growth
SBI MNC Direct Plan-Growth
Axis ELSS Tax Saver Direct Plan-Growth
HDFC Manufacturing Fund Direct - Growth
Nippon India Pharma Fund Direct-Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
Mahindra Manulife Mid Cap Fund Direct - Growth
PGIM India Midcap Fund Direct-Growth
Mirae Asset Healthcare Fund Direct - Growth 
